两名感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）并接种疫苗后出现硬斑病的患者。
Morphea in two patients after being infected to and being vaccinated against SARS-CoV-2 infection.
作者信息
Aryanian Zeinab, Balighi Kamran, Hatami Parvaneh, Tootoonchi Nasim Mazloumi, Goodarzi Azadeh, Mohseni Afshar Zeinab
机构信息
Autoimmune Bullous Diseases Research Center Tehran University of Medical Sciences Tehran Iran.
Department of Dermatology Babol University of Medical Sciences Babol Iran.
出版信息
Clin Case Rep. 2022 Apr 18;10(4):e05667. doi: 10.1002/ccr3.5667. eCollection 2022 Apr.
Although the presence of morphea following COVID-19 has been rarely reported, the development of its generalized form following COVID-19 vaccination has not been reported yet. Here, we reported the first case of generalized morphea following COVID-19 vaccination and another similar case following SARS-Cov-2 infection. Other etiologic factors were also dealt with.
尽管新冠病毒病（COVID-19）后出现硬斑病的情况鲜有报道，但新冠病毒疫苗接种后出现其泛发型的情况尚未见报道。在此，我们报告了首例新冠病毒疫苗接种后泛发性硬斑病病例以及另一例新型冠状病毒（SARS-CoV-2）感染后的类似病例。同时也探讨了其他病因。
Zotero 插件